Start for free
Start for free
LF

Lichtsteiner Foundation

Europe, Bern, Switzerland, Berne

Description

Lichtsteiner Foundation promotes discoveries in the field of medicine for the improvement of people’s health.

Investor Profile

Lichtsteiner Foundation has made 6 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (67%)
  • Series A (33%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
  • Medical
  • Health Diagnostics
  • Personal Health
  • Therapeutics
  • Genetics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lichtsteiner Foundation frequently co-invest with?

Gaingels
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
Zürcher Kantonal Bank
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
DART Ventures
DART Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
RH Capital
RH Capital
North America, California, United States, San Francisco
Co-Investments: 1
Amboy Street Ventures
Amboy Street Ventures
North America, California, United States, Los Angeles
Co-Investments: 1
BB
Bernina BioInvest
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Kurma Partners
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
EI
Essential Investment Partners
North America, Colorado, United States, Englewood
Co-Investments: 1
The Helm
The Helm
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Lichtsteiner Foundation?

Limula

La Tour-de-peilz, Vaud, Switzerland

Limula offers a modular and automated solution for on-demand and at-scale manufacturing of cell therapies.

BiotechnologyGeneticsManufacturingPharmaceutical
SeedMay 21, 2024
Amount Raised: $6,803,490
Testmate Health

Renens, Vaud, Switzerland

Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes.

BiotechnologyHealth CareHealth DiagnosticsLife SciencePersonal HealthPharmaceutical
SeedMay 2, 2024
Amount Raised: $6,000,000
Indivi

Basel, Basel-Stadt, Switzerland

Indivi (a DBA of Healios AG) is a MedTech company developing and validating digital biomarkers in neuroscience.

Clinical TrialsMedical Device
SeedAug 30, 2022
MUVON Therapeutics

Zürich, Zurich, Switzerland

Muvon Therapeutics is a biotech company developing autologous cell therapies to restore skeletal muscle.

BiotechnologyHealth CareLife Science
Series AMay 31, 2021
Microcaps

Zürich, Zurich, Switzerland

Microcaps develops a novel technology that enables the scalable production of precise microcapsules and microparticles.

BiotechnologyComputerInformation TechnologyMedical
SeedJan 26, 2021
Amount Raised: $5,638,504
Synendos Therapeutics

Allschwil, Basel-Landschaft, Switzerland

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.

Health CareMedicalTherapeutics
Series ANov 12, 2020
Amount Raised: $21,860,671
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator